AN EXPERIMENTAL TEST OF NUZUM'S ANTIPOLIOMYELITIC SERUM.

Amoss HL, Eberson F. · 1918

Read AN EXPERIMENTAL TEST OF NUZUM'S ANTIPOLIOMYELITIC SERUM. by Amoss HL, Eberson F. (1918) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2126279.txt.

Introduction

Harold L. Amoss and Frederick Eberson tested another marketed poliomyelitis serum in monkeys, this one the antistreptococcic serum of Nuzum and Willy, prepared in horses from streptococci. Their 1918 Journal of Experimental Medicine paper follows their Rosenow serum test and applies the producers' own methods against small doses of poliomyelitis virus.

Nuzum's serum showed neither neutralizing nor healing power in the monkey tests. Under the same conditions, serum from monkeys recovered from experimental poliomyelitis both neutralized the virus and protected the animals. The authors also weigh the wider claims made for streptococcus as a cause of epidemic poliomyelitis and for antistreptococcic sera as treatments, and judge that evidence weak and inconclusive. Two horse sera built on the streptococcus idea had now failed their laboratory's monkey tests in a row.

Catalog record

CREATORAmoss HL, Eberson F.
YEAR1918
COLLECTIONPAPERS
FORMATTXT
FILE SIZE22 KB
LICENSEPublic Domain
RIGHTSPUBLIC DOMAIN
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2126279

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

AN EXPERIMENTAL TEST OF NUZUM'S ANTIPOLIOMYELITIC SERUM By Harold L. Amoss, Frederick Eberson Published in: The Journal of Experimental Medicine DOI: 10.1084/jem.28.3.323 ABSTRACT The antistreptococcic serum of Nuzum and Willy has failed to show in the monkey neutralizing or therapeutic power when applied by their methods against small doses of the virus of poliomyelitis. Under the same conditions the serum of monkeys recovered from experimental poliomyelitis proved neutralizing and protective. The experimental and other evidence adduced by those who regard the streptococcus as playing an essential part in the pathology of epidemic poliomyelitis and the antistreptococcic sera as exhibiting therapeutic properties for man and monkeys is regarded as imperfect and inconclusive. AN EXPERIMENTAL TEST OF NUZUM'S ANTIPOLIOMYELITIC SERUM. BY HAROLD L. AMOSS, M.D., AND FREDERICK EBERSON, PH.D. (From the Laboratories of The Rockefeller Institute for Medical Research.) PLATES22 TO24. (Received for publication, June 8, 1918.) In a recent paper1 we reported a series of experiments with Rosenow's anti- poliomyelitic serum, which is prepared in the horse by injections of streptococci derived from cases of poliomyelitis. The present paper deals with a similar test of a serum prepared in the horse by Nuzum 2also by inoculating streptococci. The two sera--Rosenow's and Nuzum's--while apparently similar, are prepared in somewhat different manner. Thus Nuzum 3 has had the exceptional and on the whole extraordinary experience of cultivating streptococci from the cerebro- spinal fluid removed by lumbar puncture from 90 per cent of the cases of epi- demic poliomyelitis studied, and he employs these spinal strains in the immuni- zation process. Nuzum's reported results stand alon~; no other bacteriologist employing a strict technique has found bacteria either on microscopic examina- tion or in cultures in the cerebrospinal fluid. Perhaps the largest single experience reported is that of Abramson,4 who published results of the bacteriological study of more than 1,200 fluids, all being negative for bacteria aside from a few instances of obvious contaminations. However, it is imperative to approach the question of immunological relation of certain streptococci to poliomyelitis without prejudice; and as Rosenow5 and Nuzum 6 have reported the successful application of their sera, not only in ex- periments on monkeys, but also in treating human cases of the disease, it is essen- tial that confirmatory and, as far as possible, decisive tests be carried out by others. We believe that we1 have performed a decisive test with Rosenow's serum with the result of showing that under the conditions of the experiment it is de- void of protective power when injected intraspinally against experimental in- fection of monkeys with an active virus of poliomyelitis introduced intravenously. That the conditions of the experiments were not too severe is indicated by the 1Amoss, H. L., and Eberson, F., J. Exp. Med., 1918, xxvii, 309. 2Nuzum, J. W., J. Am. Med. Assn., 1916, lxvii, 1437. * ~Nuzum, J. W., J. Am. Med. Assn., 1917, lxviii, 24. 4Abramson, H. L., J. Am. Med. Assn., 1917, lxviii, 546. 5Rosenow, E. C., J. Am. Med. Assn., 1917, lxix, 1074. Nuzum, J. W., and Willy, R. G., J. Am. Med. Assn., 1917, lxix, 1247. 323 324 NUZUM~S ANTIPOLIOMYELITICSERUM fact that perfect protection was secured from the serum of monkeys which had recovered from an experimenta~ poliomyelitic infection. Nuzum7has developed a somewhat more elaborate therapeutic technique than Rosenow. Thus he bases his contention that his serum is therapeutically active <)n three sets of tests: (a) the neutralization of the virus in vitro; (b) the neutrali- :zation of the virus in vivo by intraspinal injections of the serum; (c) the neutrali- zation of the virus in vivo by combined intraspinal, intravenous, and intramus- cular injections of the serum. Hence, in order to repeat and check Nuzum's experiments, the three modes of administering the serum should be followed. Through the kindness of Dr. Nuzum we were supplied with 50 cc. .of his serum. This proved sufficient for one set of experiments, one monkey being used for each kind of test. The series of tests is there- fore a small one; and had the results not been absolutely consistent would have had no great value. But as the results were consistent, and as the control tests with the serum of recovered monkeys were equally definite, no real doubt need be entertained regarding their significance. EXPERIMENTAL. The essential condition in dealing experimentally with the virus of poliomyelitis is to possess a specimen of regular and high potency; otherwise an element of irregularity is introduced which involves many separate inoculations. Moreover, the virus should be so active as to produce infection uniformly when small doses of the Berkefeld filtrate are injected intracerebrally. A virus which acts only when relatively large doses of the unfiltered suspension are injected is certain to produce infection irregularly and, in addition,, may give confusing results, owing to traumatic and other forms of injury to the brain substance through which paralysis, weakness, and other disturbing effects are produced. Neutralization in Vitro. When one minimum lethal dose of virus filtrate is incubated in the presence or absence of complement 8' 9 with 2 cc. of serum from a Nuzum, J. W., and Willy, R. G., J. Ir~/ect. Dis., 1918, xxii, 258. 8Levaditi and Landsteiner, Compt. rend. Soc. biol, 1910, lxviii, 311. RSmer, P. H., and Joseph, K., Mi~nch. med, Woch., 1910,lvii, 568. Flexner, S., and Lewis, P. A., J, Am, Med, Assn., 1910, liv, 1780, Anderson, J. F., and Frost, W. H., J. Am. Med. Assn,, 1911, lvi, 663. 9Flexner, S., and Amoss, H. L., J. Exp. Med., 1918, xxviii, 11. HAROLD L. AMOSS AND FREDERICK EBERSON 325 monkey which has had experimental poliomyelitis and recovered, the virus is rendered non-infective for a monkey on intracerebral inocula- tion. Normal serum 9 does not possess this power. Three experiments were carried out in precisely the same manner, comparing Nuzum and Willy's serum with normal horse serum and immune monkey serum. To 2 cc. of the serum to be tested there was added 0.2 cc. of a Berkefeld filtrate of a 5 per cent suspension of glycerolated active poliomyelitic monkey cord. The mixture was incubated for 2 hours at 37 C. and placed at 4C. for 16 hours, and then injected intracerebrally into a normal monkey. Monkey A (Macacusrhesus),Control.--Apr. 12, 1918. Injected intracerebrally the incubated mixture resulting from the addition of 0.2 cc. of virus filtrate to 2 cc. of normal horse serum. Apr. 16. Excited and slow. Apr. 17, ~.m., pros- trate, moribund; p.m., died. Autopsy showed characteristic changes of poliomyelitis in the brain and cord. Monkey B (Macacus rhesus).--Apr. 12, 1918. Injected intracerebrally the incubated mixture resulting from the addition Of 0.2 cc. of v'rus filtrate to 2 cc. of Nuzum and Willy's serum. Apr. 19, a.m., marked ataxia, both arms para- lyzed (Fig. 1); p.m.,.prostrate, etherized. Microscopic examination of the nervous tissues showed typical diffuse and ex- tensive poliomyelitic lesions in medulla and spinal cord; marked perivascular in- filtration (Fig. 2), necrosis, neurophagocytosis of the ganglion cells, and focal hemorrhages in the anterior horn of the cord. Monkey C (Macacus rhesus), Immune Control.--Apr. 12, 1918. Injected in- tracerebrally the incubated mixture resulting from the addition of 0.2 cc. of virus filtrate to 2 cc. of serum drawn from a monkey which had

Read the complete text